156 related articles for article (PubMed ID: 16334159)
1. Impact of radiotherapy with and without concurrent cisplatin on lymphocyte subpopulations in cervical cancer patients.
Bachtiary B; Herbacek I; Zideck T; Knocke TH; Dimopoulos J; Poetter R; Micksche M
Anticancer Res; 2005; 25(6C):4673-8. PubMed ID: 16334159
[TBL] [Abstract][Full Text] [Related]
2. Radiotherapy-induced changes of peripheral blood lymphocyte subpopulations in cervical cancer patients: relationship to clinical response.
Eric A; Juranic Z; Tisma N; Plesinac V; Borojevic N; Jovanovic D; Milovanovic Z; Gavrilovic D; Ilic B
J BUON; 2009; 14(1):79-83. PubMed ID: 19373951
[TBL] [Abstract][Full Text] [Related]
3. Effects of concurrent cisplatinum administration during radiotherapy vs. radiotherapy alone on the immune function of patients with cancer of the uterine cervix.
Santin AD; Hermonat PL; Ravaggi A; Bellone S; Roman J; Pecorelli S; Cannon M; Parham GP
Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):997-1006. PubMed ID: 11072156
[TBL] [Abstract][Full Text] [Related]
4. Radiotherapy-induced lymphocytopenia: changes in total lymphocyte count and in lymphocyte subpopulations under pelvic irradiation in gynecologic neoplasms.
Lissoni P; Meregalli S; Bonetto E; Mancuso M; Brivio F; Colciago M; Gardani G
J Biol Regul Homeost Agents; 2005; 19(3-4):153-8. PubMed ID: 16602631
[TBL] [Abstract][Full Text] [Related]
5. Concurrent weekly cisplatin plus external beam radiotherapy and high-dose rate brachytherapy for advanced cervical cancer: a control cohort comparison with radiation alone on treatment outcome and complications.
Chen SW; Liang JA; Hung YC; Yeh LS; Chang WC; Lin WC; Yang SN; Lin FJ
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1370-7. PubMed ID: 16979836
[TBL] [Abstract][Full Text] [Related]
6. Preliminary estimation of treatment effect on uterine cervical squamous cell carcinoma in terms of tumor regression rate: comparison between chemoradiotherapy and radiotherapy alone.
Ohara K; Tanaka YO; Tsunoda H; Oki A; Satoh T; Onishi K; Kagei K; Sugahara S; Hata M; Igaki H; Tokuuye K; Akine Y; Yoshikawa H
Radiat Med; 2005 Feb; 23(1):25-9. PubMed ID: 15786748
[TBL] [Abstract][Full Text] [Related]
7. [Retrospective study of chemoradiotherapy based on cisplatin compared with radiotherapy alone for cervical cancer].
Han C; Kong WM
Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):723-6. PubMed ID: 18307894
[TBL] [Abstract][Full Text] [Related]
8. Incidence and temporal pattern of anorexia, diarrhea, weight loss, and leukopenia in patients with cervical cancer treated with concurrent radiation therapy and weekly cisplatin: comparison with radiation therapy alone.
Ohno T; Kato S; Wakatsuki M; Noda SE; Murakami C; Nakamura M; Tsujii H
Gynecol Oncol; 2006 Oct; 103(1):94-9. PubMed ID: 16527337
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant therapy changes the lymphocyte composition of tumor-draining lymph nodes in cervical carcinoma.
Fattorossi A; Battaglia A; Ferrandina G; Coronetta F; Legge F; Salutari V; Scambia G
Cancer; 2004 Apr; 100(7):1418-28. PubMed ID: 15042676
[TBL] [Abstract][Full Text] [Related]
10. [The influence of radiotherapy on T lymphocyte subpopulations analyzed by monoclonal antibodies].
Shikaura S; Sogawa M; Akagi K; Hasegawa T; Sawada S; Tanaka Y; Sawaragi I
Gan No Rinsho; 1988 Mar; 34(3):305-9. PubMed ID: 3258643
[TBL] [Abstract][Full Text] [Related]
11. Response of T lymphocyte populations in prostate cancer patients undergoing radiotherapy: influence of neoajuvant total androgen suppression.
Johnke RM; Edwards JM; Kovacs CJ; Evans MJ; Daly BM; Karlsson UL; Lee TK; Allison RR; Arastu HH; Cariveau MJ; O'Brien KF
Anticancer Res; 2005; 25(4):3159-66. PubMed ID: 16080580
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcome in posthysterectomy cervical cancer patients treated with concurrent Cisplatin and intensity-modulated pelvic radiotherapy: comparison with conventional radiotherapy.
Chen MF; Tseng CJ; Tseng CC; Kuo YC; Yu CY; Chen WC
Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1438-44. PubMed ID: 17394944
[TBL] [Abstract][Full Text] [Related]
13. Amifostine enhances recovery and expansion of peripheral FAS/CD95+ T- and NK-cell subpopulations during radiotherapy of patients with head-neck cancer.
Koukourakis GV; Baksevanis CN; Zambatis H; Gritzapis A; Maltezos E; Simopoulos C; Koukourakis MI
Int J Radiat Biol; 2009 Jan; 85(1):96-104. PubMed ID: 19205988
[TBL] [Abstract][Full Text] [Related]
14. Effect of bitter melon (Momordica charantia Linn) on level and function of natural killer cells in cervical cancer patients with radiotherapy.
Pongnikorn S; Fongmoon D; Kasinrerk W; Limtrakul PN
J Med Assoc Thai; 2003 Jan; 86(1):61-8. PubMed ID: 12678140
[TBL] [Abstract][Full Text] [Related]
15. 3D conformal HDR-brachy- and external beam therapy plus simultaneous cisplatin for high-risk cervical cancer: clinical experience with 3 year follow-up.
Pötter R; Dimopoulos J; Bachtiary B; Sissolak G; Klos B; Rheinthaller A; Kirisits C; Knocke-Abulesz TH
Radiother Oncol; 2006 Apr; 79(1):80-6. PubMed ID: 16516316
[TBL] [Abstract][Full Text] [Related]
16. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.
Hitchcock YJ; Tward JD; Szabo A; Bentz BG; Shrieve DC
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):779-88. PubMed ID: 18707819
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment proliferation and local control in bladder cancer after radiotherapy with or without concurrent chemotherapy.
Weiss C; Rödel F; Ott O; Engehausen DG; Papadopoulos T; Sauer R; Rödel C
Strahlenther Onkol; 2007 Oct; 183(10):552-6. PubMed ID: 17896086
[TBL] [Abstract][Full Text] [Related]
18. Concurrent chemoradiotherapy followed by adjuvant chemotherapy in uterine cervical cancer patients with high-risk factors.
Kim YB; Cho JH; Keum KC; Lee CG; Seong J; Suh CO; Kim GE
Gynecol Oncol; 2007 Jan; 104(1):58-63. PubMed ID: 16919718
[TBL] [Abstract][Full Text] [Related]
19. Long-term immune dysfunction after radiotherapy to the head and neck area.
Verastegui EL; Morales RB; Barrera-Franco JL; Poitevin AC; Hadden J
Int Immunopharmacol; 2003 Aug; 3(8):1093-1104. PubMed ID: 12860166
[TBL] [Abstract][Full Text] [Related]
20. Effects of treatment intensification on acute local toxicity during radiotherapy for head and neck cancer: prospective observational study validating CTCAE, version 3.0, scoring system.
Palazzi M; Tomatis S; Orlandi E; Guzzo M; Sangalli C; Potepan P; Fantini S; Bergamini C; Gavazzi C; Licitra L; Scaramellini G; Cantu' G; Olmi P
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):330-7. PubMed ID: 17881148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
